Sudden cardiac death from arrhythmias accounts for more than 10 percent of naturally occurring deaths in the United States (1). Molecular genetics has recently identified ion channel mutations involved in hereditary Long-QT syndrome (LQTS) providing tools to further our insights into mechanisms of acquired arrhythmias (2). The major repolarizing K+ currents in human myocardiocytes are IKr and IKs. These currents are produced by HERG and KvLQT1, respectively. Mutations in these two genes and a cardiac Na+ channel gene, SCNA5, have been shown to cause some forms of hereditary LQTS (4,5,6,18). Heterologous expression of these cloned channels allows detailed study of their function, however, the phenotype of cloned channels frequently differs from their behavior in native tissue. These differences have been attributed to regulation by second messengers, accessory proteins, multiple splice variants or heterologous assembly of different subunits. Our lab has developed a mammalian expression system to study the functional and biochemical properties of cloned K+ channels, accessory proteins and their interactions. We have shown that HERG physically associates with another protein, minK, and that this association regulates IKr activity (7). Using this system, we also have evidence that a dominant negative HERG mutant acts by dramatically accelerating the degradation of wild-type HERG. We hypothesize that interaction of HERG with mutant HERG subunits, regulatory proteins such as minK, and second messengers modulates K+ current expression and propensity for ventricular arrhythmias. Accordingly, we propose to study the mechanisms of ventricular arrhythmias by investigating the regulation of HERG K+ channel expression and function. To this end we will: 1. Extend functional analysis of minK and HERG interaction. 2. Investigate the mechanism of alterated IKr expression by naturally occurring mutants of HERG. 3. Investigate second-messenger effects on HERG and HERG/minKK+ currents. 4. Perform a structural analysis of the interaction between HERG and minK.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL057388-04
Application #
6389600
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Program Officer
Spooner, Peter
Project Start
1998-04-01
Project End
2002-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
4
Fiscal Year
2001
Total Cost
$308,046
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Melman, Yonathan F; Krumerman, Andrew; McDonald, Thomas V (2002) A single transmembrane site in the KCNE-encoded proteins controls the specificity of KvLQT1 channel gating. J Biol Chem 277:25187-94
Melman, Y F; Domenech, A; de la Luna, S et al. (2001) Structural determinants of KvLQT1 control by the KCNE family of proteins. J Biol Chem 276:6439-44
Kagan, A; Yu, Z; Fishman, G I et al. (2000) The dominant negative LQT2 mutation A561V reduces wild-type HERG expression. J Biol Chem 275:11241-8